AXS-05 (Dextromethorphan/Bupropion): An Innovative Treatment in Clinical Development for Agitation Associated with Alzheimer’s Disease

Alzheimer's Association International Conference [AAIC], July, 2018

AXS-05 for Neuropsychiatric Disorders: Scientific Rationale and Clinical Development

American Society of Clinical Psychopharmacology [ASCP], May 2018

Clinical Development of AXS-05 for Treatment Resistant Depression and Agitation Associated with Alzheimer’s Disease

American Psychiatric Association Conference [APA], May 2018